AAP IMPLANTATE AG NPV - DE000A3H2101 (Stock)
Stuttgart
| Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
|---|---|---|---|---|---|---|
1,41 EUR
|
0,00% | 17.04.2025 21:45 | 0,00 | - | - | 0,00 |
| Contact | |
|---|---|
|
|
aap Implantate AG Lorenzweg 5 12099, Berlin, DE |
| Phone | +49-30-750-19-134 |
| Fax | +49-30-750-19-290 |
| info@aap.de | |
| Internet | http://aap.de |
| IR Contact/PR Contact | -/- |
| Symbol | |
| End of financial year | 31.12.2025 |
| Issued capital | 20.142.714,00 EUR |
| Shareholders | |
|---|---|
| Freefloat | 94,61% |
| Discover Capital GmbH | 5,39% |
| Board | |
|---|---|
| Rubino di Girolamo | Chairman of Managing Board |
| Agnieszka Mierzejewska | Member of Executive Committee |
| Dr. Nathalie Krebs | Chairman of Supervisory Board |
| Marc Langner | Member of Supervisory Board |
| Jacqueline Rijsdijk | Member of Supervisory Board |
| Torbjörn Sköld | Member of Supervisory Board |
| Activity Description |
|---|
|
aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. It offers trauma and biomaterials products which include anatomical plating system LOCTEQ, cannulated screws, standard plates and screws, bone cements, and mixing systems. The company was founded by Uwe Ahrens in 1990 and is headquartered in Berlin, Germany. |
© 2000 - 2025 UniCredit Bank Austria AG. Please read our terms and conditions
Implemented and powered by FactSet
Fond data is provided from Mountain-View Data Gmbh
Austria-HomePage Version 2.0.54
